In the context of OSA, we have recently demonstrated CSPG4 overexpression at mRNA and protein level in human and canine OSA patients, respectively, and a possible clinical implication has been suggested by a correlation between its overexpression and a shorter survival for both OSA-affected humans and dogs [12]. Here, CSPG4 is linked to obstructive sleep apnea syndrome.